Incidence of fractures in patients with solid cancers treated with immune checkpoint inhibitors: a systematic review and meta-analysis of randomised controlled trials.

While these estimates did not reach statistical significance due to the low number of events and wide CIs, the results highlight possible fracture risk signals in specific subgroups such as patients without metastatic disease or those with prior chemotherapy exposure.

also in 111,027 other papers